Familial Transthyretin Amyloidosis - 25 Studies Found Withdrawn : The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the Heart : Amyloidosis : 2015-11-19 : Drug: Isis 420915/GSK 299872 Open label study in comparison to historic control. Recruiting : A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects : Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) : 2016-05-18 : Drug: ALN-TTRSC02 Ascending do Enrolling by invitation : The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran) : Amyloidosis : 2015-07-16 : Drug: Patisiran (ALN-TTR02) administered by intravenous (IV) infusion Active, not recruiting : Tolerability and Efficacy of a Combination of Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy : Amyloidosis; Heart (Manifestation) Senile Cardiac Amyloidosis : 2013-03-12 : Drug: Tauroursodeoxycholic Acid and Doxycycline Completed : Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers : Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) Transthyretin Cardiomyopathy (TT : 2012-05-21 : Other: No drug No drug. <<< Previous